COVID-19 Serotherapy
Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.
Year introduced: 2023 (2020)
PubMed search builder options
Subheadings:
Tree Number(s): E02.095.465.425.400.330.050.200, E05.478.550.520.050.200
MeSH Unique ID: D000093522
Entry Terms:
- Serotherapies, COVID-19
- Serotherapy, COVID-19
- COVID19 Serum Therapy
- Serum Therapies, COVID19
- Serum Therapy, COVID19
- Therapies, COVID19 Serum
- Therapy, COVID19 Serum
- Coronavirus Disease-19 Serotherapy
- Coronavirus Disease-19 Serotherapies
- Coronavirus Disease 19 Serotherapy
- Disease-19 Serotherapies, Coronavirus
- Serotherapies, Coronavirus Disease-19
- Serotherapy, Coronavirus Disease-19
- Coronavirus Disease 2019 Serotherapy
- COVID-19 Serum Therapy
- COVID-19 Serum Therapies
- Serum Therapies, COVID-19
- Serum Therapy, COVID-19
- Therapies, COVID-19 Serum
- Therapy, COVID-19 Serum
- COVID19 Serotherapy
- Serotherapies, COVID19
- Serotherapy, COVID19
- COVID-19 Convalescent Serum Treatment
- Covid-19 Convalescent Sera Treatment
- Covid 19 Convalescent Sera Treatment
- SARS-CoV-2 Convalescent Sera Treatment
- SARS-CoV-2 Convalescent Serum Treatment
- Convalescent Serum Treatment for Covid-19
- Convalescent Serum Treatment for Covid 19
- COVID-19 Convalescent Plasma Treatment
- SARS-CoV-2 Convalescent Plasma Treatment
- Convalescent Plasma Treatment for Covid-19
- Convalescent Plasma Treatment for Covid 19
- COVID-19 Hyperimmune Globulin Therapy
- COVID19 Hyperimmune Globulin Therapy
- Hyperimmune Globulin Therapy for COVID-19